Thursday
Mar012007

NCT00019097

Vaccine Therapy in Treating Patients With Multiple Myeloma

Conditions: Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Neoplasm
Sponsors: National Cancer Institute (NCI)
Phase II

PrintView Printer Friendly Version

EmailEmail Article to Friend